Lifecore Biomedical Inc (LFCR) average volume reaches $196.71K: Is Wall Street expecting a rally?

Lifecore Biomedical Inc (NASDAQ: LFCR) kicked off on Friday, down -22.32% from the previous trading day, before settling in for the closing price of $6.81. Over the past 52 weeks, LFCR has traded in a range of $3.68-$7.99.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales slid by -16.64% over the last five years. While this was happening, its average annual earnings per share was recorded -515.62%. With a float of $32.86 million, this company’s outstanding shares have now reached $37.03 million.

The firm has a total of 524 workers. Let’s measure their productivity. In terms of profitability, gross margin is 33.45%, operating margin of -19.51%, and the pretax margin is -34.31%.

Lifecore Biomedical Inc (LFCR) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Lifecore Biomedical Inc is 11.24%, while institutional ownership is 71.77%. The most recent insider transaction that took place on Jan 08 ’25, was worth 97,580. In this transaction Chief Executive Officer of this company bought 17,000 shares at a rate of $5.74, taking the stock ownership to the 559,717 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Former officer proposed sale 10,000 for $7.17, making the entire transaction worth $71,691.

Lifecore Biomedical Inc (LFCR) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -515.62% per share during the next fiscal year.

Lifecore Biomedical Inc (NASDAQ: LFCR) Trading Performance Indicators

Take a look at Lifecore Biomedical Inc’s (LFCR) current performance indicators. Last quarter, stock had a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.50.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.70 in one year’s time.

Technical Analysis of Lifecore Biomedical Inc (LFCR)

Analysing the last 5-days average volume posted by the [Lifecore Biomedical Inc, LFCR], we can find that recorded value of 0.5 million was better than the volume posted last year of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 52.29%. Additionally, its Average True Range was 0.45.

During the past 100 days, Lifecore Biomedical Inc’s (LFCR) raw stochastic average was set at 12.34%, which indicates a significant decrease from 15.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 109.28% in the past 14 days, which was higher than the 75.50% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.18, while its 200-day Moving Average is $5.91. Now, the first resistance to watch is $6.16. This is followed by the second major resistance level at $7.04. The third major resistance level sits at $7.66. If the price goes on to break the first support level at $4.66, it is likely to go to the next support level at $4.04. Should the price break the second support level, the third support level stands at $3.16.

Lifecore Biomedical Inc (NASDAQ: LFCR) Key Stats

The company with the Market Capitalisation of 195.86 million has total of 37,025K Shares Outstanding. Its annual sales at the moment are 128,260 K in contrast with the sum of 12,010 K annual income. Company’s last quarter sales were recorded 32,560 K and last quarter income was -6,570 K.